Insulinoma

Diagnosing and Treating Low Blood Sugar Levels

18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia

Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors

Clinical Study of 18F-Exendin-4 in Insulinoma

DOTATOC PET/CT for Imaging NET Patients

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors

CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia

A Multi-center Study to Evaluate the Efficacy and Safety of Pancreatic Duct Stents Placement Before the Enucleation of Insulinoma Located in the Head and Neck of the Pancreas Near the Main Pancreatic Duct

The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma

Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery

177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs

18F-FDOPA PET in Neuroendocrine Tumours

[68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients

Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors

68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH

Pasireotide in Hyperinsulinemic Hypoglycemia

Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma